Hydrochloric Acid → Pyrido-[2,3-d]-pyrimidin-7-one 48
Reaction equation
Cl.C(OC(N1CCCC(C2C=NC(NC3N=CC4C(C)=C(Br)C(=O)N(C5CCCC5)C=4N=3)=CC=2)CC1)=O)(C)(C)C.Cl.[Br:42][C:43]1[C:66](=[O:67])[N:65]([CH:68]2[CH2:72][CH2:71][CH2:70][CH2:69]2)[C:46]2[N:47]=[C:48]([NH:51][C:52]3[CH:57]=[CH:56][C:55]([N:58]4[CH2:64][CH2:63][CH2:62][NH:61][CH2:60][CH2:59]4)=[CH:54][N:53]=3)[N:49]=[CH:50][C:45]=2[C:44]=1[CH3:73].C(O)C>C(Cl)(Cl)Cl>[Br:42][C:43]1[C:66](=[O:67])[N:65]([CH:68]2[CH2:69][CH2:70][CH2:71][CH2:72]2)[C:46]2[N:47]=[C:48]([NH:51][C:52]3[CH:57]=[CH:56][C:55]([N:58]4[CH2:64][CH2:63][CH2:62][NH:61][CH2:60][CH2:59]4)=[CH:54][N:53]=3)[N:49]=[CH:50][C:45]=2[C:44]=1[CH3:73]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Hydrogen chloride gas was bubbled through a solution of 4-[6-(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridin 3-yl]-azepane-1-carboxylic acid tert-butyl ester (80 mg, 0.13 mmol) in chloroform (5 mL) for 30 min. The solvents were evaporated and the residue was titurated with ethanol (5 mL). 6-Bromo-8-cyclopentyl-2-(5-[1,4]diazepan-1-yl-pyridin-2-ylamino)-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one hydrochloride salt was collected as a yellow powder (44 mg, 0.089 mmol). MS (APCI+) 499, 501 (M+2, 100); 1H NMR δ (400 MHz, DMSO-d6) 8.84 (s, 2H), 8.13 (s, 1H), 7.66-7.64 (m, 1H), 7.42-7.39 (m, 1H), 5.86-5.82 (m, 1H), 4.36 (s, 1H), 3.81 (s, 2H), 3.60 (s, 2H), 3.16 (s, 2H), 2.09 (s, 4H), 1.99 (s, 2H), 1.79 (br, 2H), 1.60 (s, 2H), 1.05 (s, 2H); Anal. Calc'd for C23H28Br1N7O1, 0.15 HCl, 2.55 C2H5OH, 0.45 CHCl3: C, 50.79; H, 6.55; N, 14.52. Found: C, 50.83; H, 5.69; N, 14.21.
Workup
- customThe solvents were evaporated
Sources & evidence
- ORD record
- ord-15d9033a7a06497d918049058eef251a
- Source dataset
- uspto-grants-2005_08
- Patent number
- US06936612B2
Reaction notes
Loading…